Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb 11;10(2):48.
doi: 10.3390/cancers10020048.

Early Diagnosis to Improve the Poor Prognosis of Pancreatic Cancer

Masataka Kikuyama  1 , Terumi Kamisawa  2 , Sawako Kuruma  3 , Kazuro Chiba  4 , Shinya Kawaguchi  5 , Shuzo Terada  6 , Tatsunori Satoh  7
Affiliations
Review

Early Diagnosis to Improve the Poor Prognosis of Pancreatic Cancer

Masataka Kikuyama et al. Cancers (Basel). .

Abstract

Pancreatic cancer (PC) has a poor prognosis due to delayed diagnosis. Early diagnosis is the most important factor for improving prognosis. For early diagnosis of PC, patients with clinical manifestations suggestive of PC and high risk for developing PC need to be selected for examinations for PC. Signs suggestive of PC (e.g., symptoms, diabetes mellitus, acute pancreatitis, or abnormal results of blood examinations) should not be missed, and the details of risks for PC (e.g., familial history of PC, intraductal mucin producing neoplasm, chronic pancreatitis, hereditary pancreatitis, or life habit) should be understood. Multidetector computed tomography (MDCT) and magnetic resonance imaging (MRI) can be performed for diagnosing PC, but the diagnostic ability of these examinations for PC is limited. Endoscopic diagnostic procedures, such as endoscopic ultrasonography, including fine-needle aspiration, and endoscopic retrograde pancreatocholangiography, including Serial Pancreatic-juice Aspiration Cytologic Examination (SPACE), could be recommended for a detailed examination to diagnose pancreatic carcinoma earlier.

Keywords: DM; ERCP; EUS; FDG-PET; MDCT; MRI; SPACE; acute pancreatitis; carcinoma in situ; hereditary pancreatitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. UICC . TNM Classification of Malignant Tumors. 8th ed. Wiley-Blackwell; Hoboken, NJ, USA: 2017.
    1. Committee for Pancreatic Cancer Registry Japan Pancreas Society. Pancreatic Cancer Registry Report of Japan 2007. J. Jpn. Pancreas Soc. 2007;22:e1–e94. (In Japanese)
    1. Kanno A., Masamune A., Hanada K., Maguchi H., Shimizu Y., Ueki T., Hasebe O., Ohtsuka T., Nakamura M., Takenaka M., et al. Multicenter study of early pancreatic cancer in Japan. Pancreatology. 2017;17:1–7. doi: 10.1016/j.pan.2017.11.007. - DOI - PubMed
    1. Ben Q., Xu M., Ning X., Liu J., Hong S., Huang W., Zhang H., Li Z. Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur. J. Cancer. 2011;47:1928–1937. doi: 10.1016/j.ejca.2011.03.003. - DOI - PubMed
    1. Munigala S., Singh A., Gelrud A., Agarwal B. Predictors for pancreatic cancer diagnosis following new-onset diabetes mellitus. Clin. Transl. Gastroenterol. 2015;6:e118. doi: 10.1038/ctg.2015.44. - DOI - PMC - PubMed

LinkOut - more resources